KM
Kevin Mansukhbhai Satashiya
About Kevin Mansukhbhai Satashiya
Data last updated:
Kevin Mansukhbhai Satashiya is a Director at Skybert Pharmaceuticals Private Limited (since 2026). The companies operate in Pharma and Chemicals. Earlier, Kevin Mansukhbhai Satashiya was a Director at Unesto Pharma Private Limited (2019–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Skybert Pharmaceuticals Private Limited U21001GJ2026PTC171934 | Director | 10 Jan 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Unesto Pharma Private Limited U24110GJ2019PTC109176 | Director | 18 Jul 2019 | 2019 | ₹2.2 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kevin Mansukhbhai Satashiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shrut Ponkiya | 11476358 | Skybert Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kevin Mansukhbhai Satashiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kevin Mansukhbhai Satashiya
Kevin Mansukhbhai Satashiya currently holds 1 directorship: Skybert Pharmaceuticals Private Limited (Director, since 10 Jan 2026).
Kevin Mansukhbhai Satashiya was first appointed on 18 Jul 2019 as Director at Unesto Pharma Private Limited. The most recent appointment on record is 10 Jan 2026 at Skybert Pharmaceuticals Private Limited.
Kevin Mansukhbhai Satashiya held 1 earlier board appointment: Unesto Pharma Private Limited (Director, 18 Jul 2019 to 04 Mar 2022).
The current boards of Kevin Mansukhbhai Satashiya's companies include Shrut Ponkiya (Skybert Pharmaceuticals Private Limited).